HealthLynked | Global Healthcare Network - HealthLynked
I would say this is a game changer in this 8K filing released after hours regarding yesterday's press release .
I put together a summary for for those who have not looked closely at HLYK. Personally again, this is a rare Gem in the penny market and with all these forward events unfolding in my outline, this will be discovered by the larger investors/institutions very soon in conjunction with their planned up-list to Nasdaq imo...
Dr. Michael Dent, HealthLynked's CEO, stated "We are incredibly pleased to have the support of a Naples based local family office, and they have indicated a strong interest to make an additional investment at the time of our planned up-listing to the Nasdaq exchange. Naples is a great community and home to many innovative leaders across a wide range of industries. I am excited to have the support from the community in which HealthLynked is located and is working to improve healthcare for both the local community and for patients worldwide."
HealthLynked Corp. Announces the Addition of Dan Hall, VP of Arthrex, to its Board of Directors and Relocation of Corporate Headquarters to the Arthrex Campus
The big question would be, why is this multi billion dollar a year revenue company placing a VP on the HLYK board.
Then, he makes a 2 Million dollar investment into HLYK?
What may be the other plans for HYLK and the Arthrex relationship?
If you haven't dug into Arthrex and who they are yet, it may be a good idea before the other pieces to this relationship unfold. Remember, there is World Healthcare Summit conference coming up on the Arhrex Campus. led by Dr Dent of HLYK. I provided that video along with a few others below.
HealthLynked's The Future of Healthcare Summit Brings Healthcare Experts and Technology Innovators from Around the World to Naples, FloridaPress Release |
HealthLynked's The Future of Healthcare Summit Brings Healthcare Experts and Technology Innovators from Around the World to Naples, Florida | HLYK - HealthLynked Corp. | News | OTC Markets
Dr. Michael Dent, HealthLynked's CEO has developed an agenda that focuses on genomics, functional medicine, anti-aging, stem cells, artificial intelligence, diagnostic advances, telemedicine, intellectual property, tissue regeneration, cancer treatments and medical devices.
The summit venue will be open to the public on Tuesday, March 16th, where a series of Ted Talk style lectures will cover the latest healthcare trends, technology, and treatments. This open forum will allow the public the opportunity to learn about the latest advances in healthcare and how they are being applied today and what to expect in future.
HealthLynked has confirmed a world-class slate of speakers including:
Bob Gasparini, Former President NeoGenomics Laboratories Robert Mino JD, Healthcare Patent Attorney Michael Dent M.D., Chairman and CEO HealthLynked Corp and Founder NeoGenomics Laboratories Gagan Babber, Former Co-founder & CTO of Collaborate Cloud Edwardo Maristany M.D., Naples Center of Functional Medicine Attendees of the summit include doctors, hospital executives, academics, researchers, venture capitalists, pharmaceutical firms, policymakers, philanthropists, and future leaders. The seating for the summit will follow COVID-19 spacing guidelines and Arthrex campus facilities are equipped with Synexis air purification systems that kill airborne COVID-19 to add an additional layer of safety for the attendees.
Who is Arthrex? ...
A world leader in orthopedic surgical device design, research, manufacturing and medical education.
Welcome to Arthrex, a global medical device company and leader in new product development and medical education in orthopedics. With a corporate mission of Helping Surgeons Treat Their Patients Better™, Arthrex has pioneered the field of arthroscopy and develops more than 1,000 innovative products and procedures each year.
Watch these > Arthrex Medical Education Experience
Arthrex's annual revenues are over $500 million and has over 1,000 employees. It is classified as operating in the Surgical & Medical Instrument Manufacturing industry. Total Worldwide [including U.S.] Revenue in the Latest Fiscal Year 2,616,500,000